Inhibition of the pregnenolone delta 5-3 beta hydroxysteroid dehydrogenase-delta 5-4 isomerase systems of human placenta and corpus luteum of pregnancy.
D000737:Androstenols / Q000494:pharmacology; D003338:Corpus Luteum / Q000201:enzymology*; D003864:Depression, Chemical; D004794:Enzyme Repression / Q000187:drug effects; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D007535:Isomerases / Q000037:antagonists & inhibitors*; D007664:Ketosteroids / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors*; D009570:Nitriles / Q000494:pharmacology; D010084:Oxidation-Reduction; D010110:Oxymetholone / Q000494:pharmacology; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D011284:Pregnenolone; D011374:Progesterone / Q000096:biosynthesis
D000737:Androstenols; D007664:Ketosteroids; D009097:Multienzyme Complexes; D009570:Nitriles; D011374:Progesterone; D004958:Estradiol; D011284:Pregnenolone; D006913:Hydroxysteroid Dehydrogenases; D007535:Isomerases; D010110:Oxymetholone